- Understanding functional neurological disorder
- Barriers to patient acceptance
- The role of clinician communication
- Psychosocial factors influencing diagnosis acceptance
- Approaches to improve patient engagement
Functional neurological disorder (FND) encompasses a range of neurological symptoms—such as weakness, movement disorders, sensory disturbances, or non-epileptic seizures—that are inconsistent with recognised neurological disease yet are genuine and distressing to the patient. These symptoms are thought to be the result of altered brain functioning rather than structural damage, and they can be as disabling and persistent as those stemming from diagnosed neurological pathologies. Despite an increasing understanding of the mechanisms underpinning FND, patient acceptance of the diagnosis often remains a challenge due to the complex nature of the condition.
The diagnosis of FND is made through positive clinical signs rather than exclusion of other conditions. These may include inconsistency of symptoms upon examination, distractibility, or patterns that contradict typical presentations of organic neurological diseases. The use of signs such as Hoover’s sign or tremor entrainment tests can aid in reinforcing the diagnosis. Emphasis is placed on the presence of identifiable, reproducible clinical features rather than the absence of disease, which can help validate the diagnosis for patients and reinforce their therapeutic relationship with clinicians.
The terminology and explanations used when delivering the diagnosis are crucial. Terms like “functional” may seem ambiguous or even dismissive to those unfamiliar with the clinical meaning, thereby influencing patient acceptance negatively. Clear, compassionate communication that validates the patient’s experience, provides a coherent rationale for symptoms, and outlines a management plan is essential. The clinician’s ability to present FND as an understandable, reversible, and treatable disorder can significantly affect the patient’s perception and adherence to treatment strategies.
In clinical practice, a thorough understanding of FND allows healthcare professionals to build a stronger therapeutic relationship and tailor communication in ways that minimise stigma and prevent feelings of dismissal. Education about FND must likewise be conveyed not only to patients but across multidisciplinary teams to ensure consistency and support in management. Through shared understanding and trust within the therapeutic relationship, there is a higher potential for engagement, adherence to therapy, and ultimately, improvement in functional outcomes.
Barriers to patient acceptance
One of the primary barriers to patient acceptance of an FND diagnosis lies in the inherent disbelief or confusion many individuals experience upon hearing that their symptoms do not stem from an identifiable structural brain disorder. Patients may feel invalidated, suspecting that their condition is being dismissed as ‘not real’ or psychological in origin, which can lead to mistrust of the diagnosis and reluctance to engage with treatment. This resistance is particularly strong when patients have undergone lengthy diagnostic journeys, often involving numerous investigations and specialist consultations, only to be told that their symptoms are ‘functional’.
Negative connotations associated with mental health and functional disorders further complicate acceptance. Many patients associate FND with stigma, perceiving the diagnosis as a reflection of weakness or vulnerability. This perception is often influenced by cultural attitudes toward psychiatric or psychosomatic conditions, which may view such diagnoses as less legitimate or more blameworthy. Consequently, fears of being misunderstood or misdiagnosed may prompt some individuals to continue seeking alternative explanations, thereby delaying treatment and worsening outcomes.
Miscommunication or lack of clarity during the diagnostic process also significantly contributes to the challenge of patient acceptance. Without clear, empathic communication, patients may leave consultations feeling confused or dismissed. If clinicians fail to explain the mechanisms of FND in an accessible and compassionate manner, the diagnosis can appear vague or unconvincing. This undermines the therapeutic relationship and can suppress motivation to engage in recommended therapies, particularly when patients perceive the suggestions as irrelevant or misaligned with their understanding of the condition.
Another barrier is the patient’s previous medical and psychological history, which can shape how they interpret a new diagnosis. In individuals with longstanding or complex symptomatology, the shift from a presumed organic illness to a functional diagnosis can feel like a contradiction or a downgrade, especially if no prior discussions about FND or its legitimacy have taken place. Patients with coexisting mental health conditions may also fear that their symptoms will be attributed solely to psychological causes, leading to feelings of frustration or marginalisation.
Family and social dynamics can exert a powerful influence on a patient’s acceptance of the diagnosis. If family members or carers are sceptical of FND, or if the patient’s support network lacks understanding about the condition, this can reinforce doubts and hinder adherence to treatment plans. Moreover, in some cases, secondary gain from the sick role—such as attention or relief from certain responsibilities—may unconsciously reinforce symptoms and reduce the motivation to accept the diagnosis and pursue rehabilitation.
Ultimately, addressing these barriers requires a multifaceted approach that combines clear communication, validation of patient experiences, and strong therapeutic relationships. Without efforts to understand and mitigate these obstacles, there is a risk of disengagement from care, prolongation of symptoms, and increased emotional distress among individuals with FND.
The role of clinician communication
Effective communication from clinicians plays a vital role in influencing patient acceptance of an FND diagnosis. The manner in which the diagnosis is delivered can either strengthen or weaken the therapeutic relationship, ultimately affecting a patient’s willingness to engage in treatment and work toward recovery. When communication is clear, empathic, and grounded in an evidential explanation of FND, patients are more likely to feel understood and supported. Conversely, rushed or dismissive interactions risk engendering mistrust, leading patients to question the legitimacy of the diagnosis.
A key aspect of successful communication lies in the ability of clinicians to normalise FND without diminishing its seriousness. Explaining the disorder through analogies—for instance, comparing it to software problems instead of hardware failures in the brain—often helps patients grasp the concept more effectively. This enables individuals to make sense of their symptoms within a valid medical framework. Using language that reduces stigma and avoids psychological overtones unless appropriate can further aid in fostering patient acceptance. Terms like “functional symptoms” should be contextualised carefully to avoid misunderstandings that might imply the symptoms are imagined or voluntary.
Clinicians must also be prepared for emotional reactions, including disbelief, anger, or grief, when presenting an FND diagnosis. Addressing these responses with compassion and patience is crucial to maintaining trust. Providing patients with ample time to ask questions, acknowledge their concerns, and validate their lived experiences shows respect and empathy. This engagement helps mitigate feelings of alienation and empowers patients to take a proactive role in their own recovery journey.
Training in communication strategies specific to FND can significantly enhance clinician confidence and consistency in delivering the diagnosis. Workshops, simulations, and multidisciplinary discussions can equip healthcare providers with the skills necessary to present FND in a patient-centred way. Clinicians who work collaboratively with psychologists, physiotherapists, and other allied professionals are often better positioned to reinforce a unified message about the condition, promoting a stable and coherent therapeutic relationship.
Furthermore, continuity of care and follow-up discussions provide opportunities to revisit and reinforce key messages, particularly as patients process new information and begin observing symptom changes. Early introduction of treatment options, such as physiotherapy or psychological interventions tailored to FND, can also help anchor the diagnosis in action rather than theory. When patients see a clear path forward, accompanied by professional support and belief in the legitimacy of their symptoms, engagement with treatment is more likely to occur.
Clinician communication must go beyond simply delivering a diagnosis—it should involve continuous dialogue, education, reassurance, and partnership. Establishing a positive therapeutic relationship through these means is a critical determinant of how successfully a patient accepts and responds to an FND diagnosis.
Psychosocial factors influencing diagnosis acceptance
Psychosocial factors can significantly influence how patients interpret and accept a diagnosis of functional neurological disorder (FND). These factors encompass a wide range of individual, familial, societal, and cultural variables that shape health beliefs, coping strategies, expectations of illness, and perceived legitimacy of medical diagnoses. As such, they play a pivotal role in shaping patient acceptance and the development of a trusting therapeutic relationship.
Individual psychological traits can influence how a patient processes the implications of an FND diagnosis. A person with high levels of health anxiety or perfectionism may find it particularly difficult to accept a diagnosis that lacks structural pathology, perceiving it as uncertain or insufficiently ‘medical’. Patients who have experienced prior trauma or chronic stress may also exhibit heightened sensitivity to perceived invalidation or misattribution of symptoms, interpreting the communication around the diagnosis through a lens shaped by past psychological adversity.
Stigma is a key societal factor that affects acceptance. In many cultures, conditions perceived to be of psychological or functional origin may be viewed with suspicion or shame. Patients may fear being labelled as malingering or mentally ill, which can lead them to reject the diagnosis outright. Societal norms that value stoicism and view illness through a biomedical lens may further contribute to this resistance. As a result, the psychosocial environment may either support or undermine the explanations offered by clinicians, especially if patients rely heavily on external validation for understanding their illness.
Family dynamics and social influences also have a significant bearing on the process of acceptance. In some cases, families reinforce narratives of organic disease and encourage further medical investigation, either due to their own misunderstanding of FND or because of protective instincts. If a patient’s close social network expresses scepticism or contradicts the medical perspective, the resulting tension can erode the patient’s confidence in the diagnosis and impair the therapeutic relationship necessary for recovery. In contrast, families who are engaged, well-informed, and supportive can become vital allies in promoting understanding and treatment adherence.
Education level, health literacy, and prior exposure to mental health concepts can further shape how individuals perceive and accept the diagnosis. Patients with limited understanding of neurological conditions or those who lack access to accurate information about FND may interpret their symptoms through misinformed or culturally influenced frameworks. Digital media and online communities can both help and hinder this process by providing accurate resources or, conversely, validating alternative illness beliefs that contradict the clinician’s explanation.
Economic and occupational factors also intersect with psychosocial dynamics. For example, patients dependent on disability benefits or sick leave may perceive a threat to their financial stability if a diagnosis of FND is not recognised as equally disabling as a structural medical condition. Others may struggle with returning to activities that previously defined their identity, such as employment or caregiving roles, which can lead to internal conflict about accepting the diagnosis and pursuing rehabilitation.
Ultimately, integrating awareness of these psychosocial influences into clinical practice is essential. Effective communication strategies must go beyond factual explanation to consider the patient’s psychological context, cultural background, and social environment. By proactively addressing these dimensions, clinicians can foster greater patient acceptance and strengthen the therapeutic relationship required to support meaningful recovery from FND.
Approaches to improve patient engagement
Improving patient engagement in the management of functional neurological disorder (FND) requires a combination of clinical, educational, and psychological strategies that prioritise patient-centred care. A key aspect of this is fostering a supportive therapeutic relationship that empowers individuals to participate actively in their treatment and recovery. Such engagement hinges on consistent, open communication, validated experiences, and clear pathways towards improvement which are adapted to each patient’s needs and understanding.
One approach that has shown particular promise is collaborative psychoeducation. Providing patients with accessible and comprehensible information about FND, either through individual consultations or dedicated workshops, helps demystify the condition and reduces fears related to invalidation. When patients are offered a coherent explanation that links their symptoms to changes in brain functioning, rather than implying psychological weakness, there is often greater patient acceptance and motivation to engage with therapy. Tailoring this information to the patient’s cognitive level and emotional readiness further supports this engagement process.
Integrated multidisciplinary interventions also play a vital role in enhancing engagement. Services that bring together neurologists, physiotherapists, psychologists, occupational therapists, and other professionals can offer a more holistic approach to treatment. Such teams are ideally placed to reinforce consistent messages, provide unified goals, and address the complex biopsychosocial needs of patients with FND. When different aspects of care work synergistically, patients are more likely to feel supported and view their treatment journey as coherent and purposeful.
Physiotherapy tailored specifically for FND has increasingly shown value in improving symptoms and function. This approach departs from conventional physiotherapy by focusing on retraining movement patterns and reducing symptom focus, all while encouraging autonomy and positive reinforcement. Crucially, the physiotherapist’s communication style—including affirming the validity of symptoms and encouraging self-efficacy—contributes to sustaining the therapeutic relationship and encouraging continued participation in active rehabilitation programmes.
Incorporating cognitive behavioural therapy (CBT) and other psychological therapies can further enhance engagement, particularly when patients struggle with coexisting mental health difficulties such as anxiety or trauma. These interventions provide space for patients to explore their reactions to the diagnosis, challenge unhelpful beliefs, and develop strategies to manage symptoms. For some individuals, addressing psychological barriers to engagement, such as fear of movement or avoidance behaviours, can have a transformative impact on their trajectory towards recovery.
Peer support and patient-led education groups also offer additional layers of engagement. These forums can help patients normalise their experiences, reduce isolation, and draw strength from shared narratives. Hearing from others who have navigated similar diagnostic journeys and entered recovery can serve as a powerful motivator, particularly when patients are still experiencing uncertainty or disbelief. This type of support complements professional input by reinforcing positive attitudes toward engagement and enhancing the patient’s overall sense of agency.
Digital tools and remote access to services—such as telehealth consultations, educational videos, or interactive therapy platforms—can also help reach patients who may face geographical, mobility, or psychological barriers to face-to-face care. These methods, when aligned with consistent communication and a trusted therapeutic relationship, can widen access to interventions while maintaining coherence in the care pathway. Moreover, regular check-ins and follow-ups, whether in person or virtually, reinforce the clinician’s investment in the patient’s well-being and progress.
Ultimately, improving engagement means anchoring treatment strategies in empathy, consistency, and flexibility. By addressing patient concerns empathetically, reinforcing the legitimacy of FND, and cultivating a therapeutic relationship that prioritises collaboration and trust, clinicians can increase the likelihood that patients will accept their diagnosis and commit to pathways of recovery. The emphasis must always remain on enabling patients to regain control over their symptoms and their lives, fostering hope and re-establishing a sense of agency at every stage of treatment.
